[Skip to Content]
[Skip to Content Landing]
Views 56
Citations 0
Comment & Response
September 2018

Age and Treatment of Nonmelanoma Skin Cancer

Author Affiliations
  • 1Department of Dermatology, Baylor Scott & White Health, Texas A&M Health Science Center College of Medicine, Temple
JAMA Surg. 2018;153(9):866-867. doi:10.1001/jamasurg.2018.1676

To the Editor We read with great interest the research letter from Chauhan et al1 regarding the topic of surgical intervention in facial nonmelanoma skin cancer (fNMSC). The authors propose that age older than 90 years should be a relative contraindication for the treatment of fNMSC based on (1) the percentage of no residual carcinoma following excision (35.3% in the study) and (2) patient longevity. We agree these claims warrant further discussion; however, several points need clarification.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×